|
Volumn 47, Issue 2, 2004, Pages 107-113
|
Synthesis and characterization of tritium labeled 2,3,4,9-tetrahydro-1H-carbazoles as potent DP receptor antagonists
|
Author keywords
DP receptor antagonists; Labeled compounds; Tetrahydrocarbazole; Tritium; Tritium bromine exchange
|
Indexed keywords
REGIOSELECTIVITY;
TRITIUM;
ARYL BROMIDES;
DP RECEPTOR ANTAGONIST;
LABELED COMPOUND;
RADIOCHEMICAL PURITY;
RECEPTOR ANTAGONISTS;
SPECIFIC ACTIVITY;
SYNTHESIS AND CHARACTERIZATIONS;
SYNTHESISED;
TETRAHYDROCARBAZOLES;
TRITIUM-BROMINE EXCHANGE;
BROMINE;
2,3,4,9 TETRAHYDRO 1H CARBAZOLE DERIVATIVE;
3 CHLOROBENZOIC ACID;
6 BROMO 9 (4 CHLOROBENZYL) 1 [2 (8,8 DIMETHYL 2,2 DIOXIDOTETRAHYDRO 3A,6 METHANO 2,1 BENZISOTHIAZOL 1 YL) 2 OXOETHYL] 8 (METHYLSULFINYL) 2,3,4,9 TETRAHYDRO 1H CARBAZOLE;
6 BROMO 9 (4 CHLOROBENZYL) 1 [2 [8,8 DIMETHYL 2,2 DIOXIDOTETRAHYDRO 3A,6 METHANO 2,1 BENZISOTHIAZOL 1(4H) YL] 2 OXOETHYL] 8 (METHYLTHIO) 2,3,4,9 TETRAHYDRO 1H CARBAZOLE;
6 BROMOCARBAZOLE;
ACYLSULTAMCARBAZOLE;
BROMINE;
CARBAZIC ACID DERIVATIVE;
CARBAZOLE DERIVATIVE;
PROSTAGLANDIN D2 DERIVATIVE;
PROSTAGLANDIN D2 RECEPTOR ANTAGONIST;
PROSTAGLANDIN RECEPTOR;
PROSTAGLANDIN RECEPTOR BLOCKING AGENT;
PYRIDINIUM DERIVATIVE;
PYRIDINIUM TRIBROMIDE;
SULFIDE;
TRITIUM;
UNCLASSIFIED DRUG;
[6 BROMO 9 (4 CHLOROBENZYL) 8 (METHYLSULFINYL) 2,3,4,9 TETRAHYDRO 1H CARBAZOL 1 YL]ACETIC ACID;
ARTICLE;
BROMINATION;
CATALYSIS;
DIASTEREOISOMER;
DRUG ACTIVITY;
DRUG MIXTURE;
DRUG POTENCY;
DRUG PURITY;
DRUG RECEPTOR BINDING;
DRUG SPECIFICITY;
DRUG SYNTHESIS;
ENANTIOMER;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HYDROLYSIS;
ISOTOPE LABELING;
OXIDATION;
PROCESS CONTROL;
PRODUCT RECOVERY;
PROSTAGLANDIN METABOLISM;
RADIOCHEMISTRY;
SEPARATION TECHNIQUE;
TRITIUM;
|
EID: 1542373711
PISSN: 03624803
EISSN: None
Source Type: Journal
DOI: 10.1002/jlcr.803 Document Type: Article |
Times cited : (2)
|
References (2)
|